ZA971279B - Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors - Google Patents
Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitorsInfo
- Publication number
- ZA971279B ZA971279B ZA971279A ZA971279A ZA971279B ZA 971279 B ZA971279 B ZA 971279B ZA 971279 A ZA971279 A ZA 971279A ZA 971279 A ZA971279 A ZA 971279A ZA 971279 B ZA971279 B ZA 971279B
- Authority
- ZA
- South Africa
- Prior art keywords
- receptor antagonists
- serotonin reuptake
- overcoming
- inhinitors
- pct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96200380 | 1996-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA971279B true ZA971279B (en) | 1998-08-14 |
Family
ID=8223676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA971279A ZA971279B (en) | 1996-02-15 | 1997-02-14 | Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors |
Country Status (11)
Country | Link |
---|---|
US (1) | US5990159A (de) |
EP (1) | EP0977558B1 (de) |
JP (1) | JP2000516198A (de) |
KR (1) | KR100469029B1 (de) |
AT (1) | ATE250931T1 (de) |
AU (1) | AU1767997A (de) |
CA (1) | CA2237582C (de) |
DE (1) | DE69725345T2 (de) |
ES (1) | ES2208870T3 (de) |
WO (1) | WO1997029739A2 (de) |
ZA (1) | ZA971279B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6133253A (en) * | 1996-12-10 | 2000-10-17 | Abbott Laboratories | 3-Pyridyl enantiomers and their use as analgesics |
TW548103B (en) | 1997-07-11 | 2003-08-21 | Janssen Pharmaceutica Nv | Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
AU1230800A (en) * | 1998-11-02 | 2000-05-22 | Alza Corporation | Controlled delivery of antidepressants |
TW570920B (en) * | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
US20040092511A1 (en) * | 1999-12-10 | 2004-05-13 | Billstein Stephan Anthony | Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
GB0211230D0 (en) * | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
TW200402289A (en) * | 2002-05-17 | 2004-02-16 | Wyeth Corp | Methods of treating gastrointestinary and genitourinary pain disorders |
FR2846559B1 (fr) | 2002-10-31 | 2007-06-15 | Centre Nat Rech Scient | Composition pharmaceutique pour la preparation d'un medicament destine a traiter et/ou a prevenir une pathologie liee a une conduite obsessionnelle |
ATE359079T1 (de) * | 2003-01-13 | 2007-05-15 | Dynogen Pharmaceuticals Inc | Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus |
JP2006516976A (ja) * | 2003-01-13 | 2006-07-13 | ダイノゲン ファーマシューティカルズ,インコーポレイテッド | 機能性腸障害を処置する方法 |
CN104383542B (zh) | 2003-04-08 | 2017-09-26 | 普罗热尼奇制药公司 | 包含甲基纳曲酮的药物配方 |
WO2006105117A2 (en) * | 2005-03-28 | 2006-10-05 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
US8338446B2 (en) | 2007-03-29 | 2012-12-25 | Wyeth Llc | Peripheral opioid receptor antagonists and uses thereof |
PE20130480A1 (es) | 2007-03-29 | 2013-05-08 | Progenics Pharm Inc | Compuestos heterociclicos como antagonistas del receptor opioide periferico |
EP3263571B2 (de) | 2007-03-29 | 2023-08-23 | Progenics Pharmaceuticals, Inc. | Kristallform von (r)-n-methylnaltrexonebromide und verwendungen davon |
WO2009099411A1 (en) | 2008-02-06 | 2009-08-13 | Progenics Pharmaceuticals, Inc. | Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone |
CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
IT1392333B1 (it) * | 2008-12-16 | 2012-02-28 | Giofarma S R L | Preparazione farmaceutica per il trattamento di patologie depressive, contenente una proteina con elevato rapporto triptofano/lnaa |
WO2017127721A1 (en) * | 2016-01-21 | 2017-07-27 | The Trustees Of Columbia University In The City Of New York | Prevention of ssri-induced gastrointestinal dysfunction with a 5-ht4 receptor antagonist |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8072691A (en) * | 1990-06-28 | 1992-01-23 | Beecham Group Plc | Pharmaceutical preparations |
GB9316195D0 (en) * | 1993-08-05 | 1993-09-22 | Smithkline Beecham Plc | Pharmaceuticals |
AU4350493A (en) * | 1992-06-27 | 1994-01-24 | Smithkline Beecham Plc | Medicaments containing 5-ht4 receptor antagonists |
GB9221468D0 (en) * | 1992-10-13 | 1992-11-25 | Smithkline Beecham Plc | Pharmaceuticals |
GB9310582D0 (en) * | 1993-05-22 | 1993-07-07 | Smithkline Beecham Plc | Pharmaceuticals |
-
1997
- 1997-02-07 WO PCT/EP1997/000586 patent/WO1997029739A2/en active IP Right Grant
- 1997-02-07 KR KR10-1998-0703729A patent/KR100469029B1/ko not_active IP Right Cessation
- 1997-02-07 US US09/117,974 patent/US5990159A/en not_active Expired - Lifetime
- 1997-02-07 DE DE69725345T patent/DE69725345T2/de not_active Expired - Lifetime
- 1997-02-07 AT AT97903247T patent/ATE250931T1/de not_active IP Right Cessation
- 1997-02-07 JP JP09528960A patent/JP2000516198A/ja active Pending
- 1997-02-07 CA CA002237582A patent/CA2237582C/en not_active Expired - Lifetime
- 1997-02-07 EP EP97903247A patent/EP0977558B1/de not_active Expired - Lifetime
- 1997-02-07 ES ES97903247T patent/ES2208870T3/es not_active Expired - Lifetime
- 1997-02-07 AU AU17679/97A patent/AU1767997A/en not_active Abandoned
- 1997-02-14 ZA ZA971279A patent/ZA971279B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE69725345D1 (de) | 2003-11-06 |
CA2237582C (en) | 2009-04-14 |
CA2237582A1 (en) | 1997-08-21 |
EP0977558A2 (de) | 2000-02-09 |
ATE250931T1 (de) | 2003-10-15 |
JP2000516198A (ja) | 2000-12-05 |
ES2208870T3 (es) | 2004-06-16 |
AU1767997A (en) | 1997-09-02 |
KR19990067698A (ko) | 1999-08-25 |
US5990159A (en) | 1999-11-23 |
KR100469029B1 (ko) | 2005-05-27 |
WO1997029739A2 (en) | 1997-08-21 |
WO1997029739A3 (en) | 1999-10-28 |
EP0977558B1 (de) | 2003-10-01 |
DE69725345T2 (de) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA971279B (en) | Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors | |
MX9702865A (es) | Agentes estrogenicos. | |
IL125735A (en) | Pharmaceutical compositions for the treatment of glaucoma comprising an inhibitor of serine-threonine kinase, tyrosine kinase or protein tyrosine phosphatase or an actin-disrupting compound | |
MY141384A (en) | Prevention of loss and restoration of bone mass by certain prostaglandin agonists | |
HUT73807A (en) | 5-ht1-like indole derivatives and pharmaceutical compositions containing them | |
CY2461B1 (en) | Polymorphic compounds. | |
YU80902A (sh) | Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže | |
NO995887D0 (no) | Farmasöytiske blandinger inneholdende eletripan hemisulfat og koffein | |
AP1424A (en) | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens. | |
ZA965235B (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders | |
AP9801269A0 (en) | Prostaglandin agonists. | |
CA2378428A1 (en) | Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes | |
UA50808C2 (uk) | Композиція для лікування респіраторного дистрес-синдрому дорослих або респіраторного дистрес-синдрому новонароджених | |
EP1244452A4 (de) | Urotensin-ii rezeptorantagonisten | |
AU8361198A (en) | Novel compounds | |
AP1402A (en) | Prevention of migraine recurrence. | |
CY2039B1 (en) | 5-HT 1-like receptor agonist for rectal administration | |
MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
BG102661A (en) | Benzo/o/quinolysine derivatives, their preparation and application as 5a-reductase inhibitors | |
ES2159260A1 (es) | Nueva composicion de metanosulfonato de paroxetina | |
BG102229A (en) | Endothelium receptor antagonists | |
AU3267097A (en) | Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use | |
CA2203078A1 (en) | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents |